Ozempic & Wegovy: How Weight Loss Drugs Are Changing Restaurant Menus

The growing popularity of GLP-1 receptor agonists – a class of drugs initially developed for type 2 diabetes, now widely used for weight loss – is quietly reshaping the restaurant industry. As more Americans experience reduced appetites and altered cravings thanks to medications like Ozempic, Wegovy, and Zepbound, restaurants are adapting their menus to cater to this evolving clientele.

These medications work by mimicking a natural hormone that regulates appetite and slows digestion, leading to feelings of fullness and reduced food intake. This shift in eating patterns is prompting restaurants to rethink portion sizes, prioritize protein and fiber, and even introduce dedicated menus for GLP-1 users.

Barry Gutin, co-founder of the Cuba Libre Restaurant and Rum Bar chain, observed this trend firsthand. “I think it’s not a fad,” Gutin stated. “I think it’s a significant shift in the way people are eating. And, you know, there’s a great deal of obesity in the U.S. And other countries, and these drugs are becoming more popular, easier to get, less expensive. They’re moving from injectables to pills. So I see it gaining steam.” The impetus for change came directly from diners themselves.

“Actually, two friends of mine at different tables on the same night were on GLP-1 drugs and were teaching me how they have to eat,” Gutin explained. “And one had suggested, ‘Why don’t you have a special menu for us?’ I thought it was a good idea.”

The key, Gutin learned, isn’t simply about smaller portions. Individuals on GLP-1 medications have specific nutritional needs. “It’s more than that. Their appetite was quite small,” he said. “So first of all, it has to look delicious and smell delicious so that they feel like they want to eat. And also, they’re always concerned about the nutrients because with a small appetite, if they don’t eat the right food, they can get muscle loss. It can affect their gastrointestinal tract and the way it’s working.”

To address these concerns, Cuba Libre collaborated with a weight loss specialist, Dr. Charlie Seltzer, to develop five dishes featuring high protein, high fiber, moderate to low fat, and controlled calorie counts, offered at adjusted prices. “We placed them at smaller prices, to be fair,” Gutin noted. The goal wasn’t just to accommodate GLP-1 users, but to avoid alienating other diners. “We didn’t want people to not choose our restaurant because People can’t serve their needs.”

The focus on nutritional balance extends to carbohydrate intake. “We have to keep that small, so it’s nutritionally balanced, and they get what they need,” Gutin explained. He highlighted the restaurant’s updated take on a traditional Cuban dish, ropa vieja – a braised and shredded beef brisket with tomatoes, bell peppers, and onions. While the dish still includes rice and beans, the portion size is reduced to ensure adequate protein and fiber intake. Similar adjustments have been made to chicken, salmon, and shrimp dishes.

Cuba Libre’s response isn’t isolated. Smoothie King introduced a “GLP-1 menu” in 2024, featuring smoothies with added protein and fiber and zero added sugar. Other national chains, including Olive Garden, Shake Shack, Subway, and Chipotle, are also promoting GLP-1-friendly options. Olive Garden, for example, added a “lighter portion” section to its menu in December, offering smaller and more affordable entrees.

Gutin acknowledges the potential financial implications of offering smaller portions and potentially lower-revenue meals. However, he views it as an opportunity. “I’m trying not to think of it as a risk. I’m trying to think of it as an opportunity. If we can super-serve these guests and they have a group of people, we may gain that group of people because the GLP-1 diner knows that he can get what he needs there.”

Interestingly, the demand for smaller portions extends beyond GLP-1 users. Cuba Libre has begun incorporating three of its GLP-1 dishes into its main menu, under a section titled “Lighter portions, lighter prices, nutritionally balanced,” to appeal to a broader audience seeking healthier options. Early data suggests this strategy is working, with approximately 25% of ropa vieja orders now being for the lighter portion size.

The rise of GLP-1 medications and their impact on eating habits represent a significant shift in the food service landscape. As the use of these drugs continues to increase – a November 2025 poll from the Kaiser Family Foundation found that 12% of Americans reported taking a GLP-1 drug, double the amount from May 2025 – restaurants are likely to continue adapting their offerings to meet the evolving needs of their customers. This adaptation isn’t just about accommodating a new dietary requirement; it’s about recognizing a broader trend toward mindful eating and a greater emphasis on nutritional balance.